Rep. Lisa C. McClain sold Teleflex (TFX)
Rep. Lisa C. McClain (R-MI-9) · $1K–$15K · traded Jul 22, 2025
- Transaction
- Sold
- Amount
- $1K–$15K
- Owner
- Spouse
- Traded
- Jul 22, 2025
- Disclosed
- Aug 13, 2025
- Days to disclose
- 22
- Asset type
- Stock
- As filed
- Teleflex Incorporated Common Stock
- Industry
- Medical - Instruments & Supplies · Healthcare
Other trades in this filing
All of McClain's trades →- Aug 13, 2025$1K–$15K
$1K–$15K · Traded Aug 4, 2025 · disclosed Aug 13, 2025 · Spouse
- Aug 13, 2025$1K–$15K
Sold Arthur J. Gallagher & AJG
$1K–$15K · Traded Aug 4, 2025 · disclosed Aug 13, 2025 · Spouse
Committee overlap: Financial Services - Aug 13, 2025$1K–$15K
Sold (partial) Applied Materials AMAT
$1K–$15K · Traded Aug 4, 2025 · disclosed Aug 13, 2025 · Spouse
- Aug 13, 2025$1K–$15K
Sold (partial) Amazon.com AMZN
$1K–$15K · Traded Aug 4, 2025 · disclosed Aug 13, 2025 · Spouse
- Aug 13, 2025$1K–$15K
$1K–$15K · Traded Jul 22, 2025 · disclosed Aug 13, 2025 · Spouse
- Aug 13, 2025$1K–$15K
$1K–$15K · Traded Jul 22, 2025 · disclosed Aug 13, 2025 · Spouse
Got $1K from the company’s PAC - Aug 13, 2025$1K–$15K
$1K–$15K · Traded Jul 22, 2025 · disclosed Aug 13, 2025 · Spouse
- Aug 13, 2025$1K–$15K
$1K–$15K · Traded Jul 22, 2025 · disclosed Aug 13, 2025 · Spouse
- Aug 13, 2025$1K–$15K
$1K–$15K · Traded Jul 22, 2025 · disclosed Aug 13, 2025 · Spouse
- Aug 13, 2025$1K–$15K
Sold (partial) Novartis AG NVS
$1K–$15K · Traded Jul 22, 2025 · disclosed Aug 13, 2025 · Spouse
- Aug 13, 2025$1K–$15K
$1K–$15K · Traded Jul 22, 2025 · disclosed Aug 13, 2025 · Spouse
- Aug 13, 2025$1K–$15K
$1K–$15K · Traded Jul 22, 2025 · disclosed Aug 13, 2025 · Spouse
- Aug 13, 2025$1K–$15K
$1K–$15K · Traded Jul 22, 2025 · disclosed Aug 13, 2025 · Spouse
- Aug 13, 2025$1K–$15K
Bought McCormick & Company MKC
$1K–$15K · Traded Jul 22, 2025 · disclosed Aug 13, 2025 · Spouse
- Aug 13, 2025$1K–$15K
$1K–$15K · Traded Jul 22, 2025 · disclosed Aug 13, 2025 · Spouse
- Aug 13, 2025$1K–$15K
$1K–$15K · Traded Jul 22, 2025 · disclosed Aug 13, 2025 · Spouse
- Aug 13, 2025$1K–$15K
$1K–$15K · Traded Jul 22, 2025 · disclosed Aug 13, 2025 · Spouse
- Aug 13, 2025$1K–$15K
$1K–$15K · Traded Jul 22, 2025 · disclosed Aug 13, 2025 · Spouse
- Aug 13, 2025$1K–$15K
$1K–$15K · Traded Jul 22, 2025 · disclosed Aug 13, 2025 · Spouse
Committee overlap: Financial Services - Aug 13, 2025$1K–$15K
$1K–$15K · Traded Jul 22, 2025 · disclosed Aug 13, 2025 · Spouse
Recent Congress trades in TFX
- Aug 13, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Jul 16, 2025 · disclosed Aug 13, 2025 · Spouse
- Mar 27, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
$1K–$15K · Traded Feb 25, 2025 · disclosed Mar 27, 2025
- Nov 8, 2023$1K–$15K
- Aug 13, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
$15K–$50K · Traded Jul 12, 2023 · disclosed Aug 13, 2023
- May 19, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
$15K–$50K · Traded Apr 10, 2023 · disclosed May 19, 2023
- Dec 1, 2014$15K–$50K
Sen. Susan M. Collins (R-ME)
$15K–$50K · Traded Nov 10, 2014 · disclosed Dec 1, 2014 · Spouse
Company context for TFX
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
TFX: third_quarter 2026 lobbying report
Issues related to medical device tariffs. Issues related to physician reimbursement, prior authorization, breakthrough medical devices, and obesity treatments.
Public: Oct 19, 2026, 2:14 PM EDTOriginal source ↗TFX: third_quarter 2026 lobbying report
Educated key government stakeholders on Teleflexs research and development capabilities in support of US Service members. Educated key government stakeholders on Teleflexs research and development capabilities in support of US Service members.
Public: Oct 8, 2026, 3:05 PM EDTOriginal source ↗TFX: second_quarter 2026 lobbying report
Issues related to physician reimbursement, prior authorization, breakthrough medical devices, and obesity treatments. Issues related to medical device tariffs.
Public: Jul 20, 2026, 4:43 PM EDTOriginal source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.